AMPE News and Press, Ampio Pharmaceuticals Inc. From 08/03/22

Ampio Pharmaceuticals ( NYSE: AMPE ), a clinical-stage company focused on osteoarthritic pain, disclosed its plans to cut its staff count by more than 50% on Wednesday after a decision to end the development of a major clinical program targeted at conditions including COVID-19...

Ampio Pharmaceuticals Issues Letter to Stockholders PR Newswire ENGLEWOOD, Colo. , Aug. 3, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors in penny stocks know that they are an inherently risky proposition. That goes double for any investor just getting into this market. But with great risk comes great reward. In this case, I think these are penny s...

Ampio Pharmaceuticals (NYSE:AMPE), a company focused on immunomodulatory therapies, is trading lower in the post-market Thursday as investors react to its plans to discontinue the COVID-19 program for experimental therapy Ampion. Issuing a letter to shareholders, Ampion (AMPE) Chief Executive...

Ampio Pharmaceuticals press release (NYSE:AMPE): Q1 GAAP EPS of -$0.03 misses by $0.01. Cash and cash equivalents on March 31, 2022, totaled $28.8 million, compared to $33.9 million as of December 31, 2021. For further details see: Ampio Pharmaceuticals GAAP EPS of -$0.03 misses by $0.0...

Ampio Pharmaceuticals Reports First-Quarter Financial Results PR Newswire ENGLEWOOD, Colo. , May 16, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory th...

Ampio Independent Committee to Conduct Investigation PR Newswire ENGLEWOOD, Colo. , May 16, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio" or the "Company") today announced that an independent special committee of the...

Ampio Pharmaceuticals, Inc. to Hold Conference Call PR Newswire ENGLEWOOD, Colo. , April 27, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the ...

3 Penny Stocks to Watch That Are Climbing Right Now Finding the best penny stocks to buy can be tricky given the volatile nature of the stock market. However, there are certain stocks that tend to be worth watching and investing in. These stocks usually have a few things in common, such...

Ampio Pharmaceuticals' (NYSE:AMPE) said the U.S. Food and Drug Administration (FDA) did not agree with proposed changes made to a phase 3 trial for pain drug Ampion and that the company should have sought the regulator's nod before unblinding the data. The company was evaluatin...